Curcumin-mediated regulation of intestinal barrier function: The mechanism underlying its beneficial effects

ABSTRACT

Curcumin has anti-inflammatory, anti-oxidant and anti-proliferative properties established largely by in vitro studies. Accordingly, oral administration of curcumin beneficially modulates many diseases including diabetes, fatty-liver disease, atherosclerosis, arthritis, cancer and neurological disorders such as depression, Alzheimer's or Parkinson's disease. However, limited bioavailability and inability to detect curcumin in circulation or target tissues has hindered the validation of a causal role. We established curcumin-mediated decrease in the release of gut bacteria-derived lipopolysaccharide (LPS) into circulation by maintaining the integrity of the intestinal barrier function as the mechanism underlying the attenuation of metabolic diseases (diabetes, atherosclerosis, kidney disease) by curcumin supplementation precluding the need for curcumin absorption. In view of the causative role of circulating LPS and resulting chronic inflammation in the development of diseases listed above, this review summarizes the mechanism by which curcumin affects the several layers of the intestinal barrier and, despite negligible absorption, can beneficially modulate these diseases.

KEYWORDS:

• Chronic inflammation
• Curcumin
• Endotoxemia
• Intestinal Barrier
• Lipopolysaccharide
• Para-cellular Transport
• Tight Junctions

Acknowledgments

This work was partially supported by Basic Innovative Science Award (1-16-IBS-105) from the American Diabetes Association to SG.

Additional information

Funding

This work was supported by the American Diabetes Association (ADA) (1-16-IBS-105).